Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC; Correction, 46420 [2024-11746]
Download as PDF
<![CDATA[
46420
Federal Register / Vol. 89, No. 104 / Wednesday, May 29, 2024 / Notices
Issued: May 22, 2024.
Lisa Barton,
Secretary to the Commission.
DEPARTMENT OF JUSTICE
[FR Doc. 2024–11726 Filed 5–28–24; 8:45 am]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Prohibited
Persons Questionnaire—ATF Form
8620.57
[OMB Number 1140–0114]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 30-Day notice.
AGENCY:
Drug Enforcement Administration
[Docket No. DEA–1357]
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice; correction.
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register on
May 6, 2024, concerning an application
for a Bulk Manufacturer of Controlled
Substances. A request was made for the
removal of the following information:
‘‘The company plans to bulk
manufacture the listed controlled
substances for the purpose of producing
material for clinical trials.’’ Please
correct notice to read as follows as
stated under Supplementary
Information.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register on May 6,
2024, in FR Doc. 2024–09805, (89 FR
37260), 37260–37261 (2 pages). The
purpose is to manufacture bulk
noroxymorphone as an intermediate
product to be sold to a customer who
will indicate a Contract Manufacturer
Organization (CMO), which the material
will be shipped to, to be converted to a
non-controlled substance.
Oxymorphone (9652) will be used as a
starting material to be converted to
Noroxymorphone (9668).
No other activities for these drug
codes are authorized for this
registration.
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Oxymorphone ..................
Noroxymorphone .............
I
Drug
code
Schedule
9652
9668
II
II
I
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–11746 Filed 5–28–24; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:05 May 28, 2024
Jkt 262001
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until June
28, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact: Jaclyn N. Wiltshire, by email at
Niki.Wiltshire@atf.gov, or by telephone
at 202–648–9260.
SUPPLEMENTARY INFORMATION: The
proposed information collection was
previously published in the Federal
Register, volume 89 page 19879, on
Wednesday, March 20, 2024, allowing a
60-day comment period. Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
SUMMARY:
Bulk Manufacturer of Controlled
Substances Application: Pharmaron
Manufacturing Services (US) LLC;
Correction
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1140–0114. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a previously approved
collection.
2. Title of the Form/Collection:
Prohibited Persons Questionnaire.
3. Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: ATF Form 8620.57.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected Public: Individuals or
households.
Abstract: The Prohibited Persons
Questionnaire (ATF F 8620.57) is used
to collect personally identifiable
information (PII), to begin the eligibility
determination process for granting a
candidate (respondent) access to ATF
information, IT systems, and/or
unescorted access to ATF facilities. This
collection relates to respondent
prohibitions to possess or receive
firearms or explosives as described in
ATF-enforced statutes 18 U.S.C. 922(g)
or (n), and/or 18 U.S.C. 842(i). The
proposed information collection (IC)
OMB 1140–0114 is being revised due to
minor material changes to the form,
such as removing references to the
declination statement and signature/
date fields associated with the
declination statement.
E:\FR\FM\29MYN1.SGM
29MYN1
]]>Agencies
[Federal Register Volume 89, Number 104 (Wednesday, May 29, 2024)]
[Notices]
[Page 46420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11746]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1357]
Bulk Manufacturer of Controlled Substances Application: Pharmaron
Manufacturing Services (US) LLC; Correction
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) published a document
in the Federal Register on May 6, 2024, concerning an application for a
Bulk Manufacturer of Controlled Substances. A request was made for the
removal of the following information: ``The company plans to bulk
manufacture the listed controlled substances for the purpose of
producing material for clinical trials.'' Please correct notice to read
as follows as stated under Supplementary Information.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register on May 6, 2024, in FR Doc. 2024-09805, (89
FR 37260), 37260-37261 (2 pages). The purpose is to manufacture bulk
noroxymorphone as an intermediate product to be sold to a customer who
will indicate a Contract Manufacturer Organization (CMO), which the
material will be shipped to, to be converted to a non-controlled
substance. Oxymorphone (9652) will be used as a starting material to be
converted to Noroxymorphone (9668).
No other activities for these drug codes are authorized for this
registration.
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Oxymorphone............................. 9652 II
Noroxymorphone.......................... 9668 II
------------------------------------------------------------------------
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-11746 Filed 5-28-24; 8:45 am]
BILLING CODE 4410-09-P
